Doctor Martin Frydland

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

Membership: ACVC Member

Follow

Contributor content

Diabetic patients with cardiogenic shock randomized to treatment with microaxial flow pump vs standard care

Presentation

Diabetic patients with cardiogenic shock randomized to treatment with microaxial flow pump vs standard care

Intensive cardiac care unit management: from gas exchange to haemodynamics

Presentation

Intensive cardiac care unit management: from gas exchange to haemodynamics

Admission plasma concentration of neutrophil gelatinase-associated lipocalin and -C-reactive protein have additive prognostic value in patients with STEMI

Presentation

Admission plasma concentration of neutrophil gelatinase-associated lipocalin and -C-reactive protein have additive prognostic value in patients with STEMI

Novel biomarkers in CS: how can they guide initial management?

Presentation

Novel biomarkers in CS: how can they guide initial management?

Atrial fibrillation is associated with mortality and increased admission biomarkers reflecting neurohormonal activation and inflammation in patients with ST-elevation myocardial infarction

Presentation

Atrial fibrillation is associated with mortality and increased admission biomarkers reflecting neurohormonal activation and inflammation in patients with ST-elevation myocardial infarction

Patients with rheumatic disease experiencing ST-elevation myocardial infarction have increased inflammatory- and neurohormonal response and higher 1-year mortality

Presentation

Patients with rheumatic disease experiencing ST-elevation myocardial infarction have increased inflammatory- and neurohormonal response and higher 1-year mortality

Neutrophil Gelatinase-Associated Lipocalin (NGAL) measured at admission is associated with development of late cardiogenic shock and mortality in patients with STEMI

Presentation

Neutrophil Gelatinase-Associated Lipocalin (NGAL) measured at admission is associated with development of late cardiogenic shock and mortality in patients with STEMI

Case 2: Myocardial revascularisation in patients with cardiogenic shock.

Presentation

Case 2: Myocardial revascularisation in patients with cardiogenic shock.

Case 1: Is my patient already in shock?

Presentation

Case 1: Is my patient already in shock?

Patients with cardiogenic and septic shock have different temporal changes in inflammatory biomarkers after ICU admission

Presentation

Patients with cardiogenic and septic shock have different temporal changes in inflammatory biomarkers after ICU admission

ESC 365 is supported by

novartis

Explore sponsored resources